Skip to content
Open access

Cross-Species Efficacy of Combinatorial Gene Therapy for Osteoarthritis and Correction of Neuro-Inflammatory Pain Mechanisms

Jul 2026 · bioRxiv · 0 citations
Biology Medicine

TL;DR

A single intra-articular injection of a combinatorial gene therapy slows OA progression and reduces pain in small and large animal models, and identifies neuroinflammatory signatures for correction of disease progression and pain.

Read PDF

Similar papers

Review Open access Aug 2026

Biologic and regenerative strategies for osteoarthritis: advances in MSC, exosome, and PRP based therapies

Biologic and regenerative interventions represent promising avenues for advancing cartilage repair and improving clinical outcomes in patients with osteoarthritis, and current evidence indicates that these therapies exert their effects through modulation of inflammatory pathways, enhancement of extracellular matrix syn...

Hai-Yuan Yue, Ahmad Alhaskawi, S. Ezzi et al. · 0 citations
Review Open access Sep 2026

Application of affinity peptides in stem cell therapy for osteoarthritis

Osteoarthritis (OA) is a prevalent degenerative joint disease characterized by cartilage degradation, synovial inflammation, and subchondral bone changes, leading to chronic pain and functional impairment. Current treatments primarily alleviate symptoms but fail to halt disease progression or achieve cartilage regene...

Hao-Ran Zhu, Jin-Yang He, Yu-Jing Chen et al. · 0 citations
Review Open access Sep 2026

Resolution of Inflammation: A Novel Therapeutic Paradigm for Rheumatoid Arthritis and Its Comorbidities.

Rheumatoid arthritis (RA) is a systemic immune-mediated disease in which persistent synovial inflammation contributes not only to joint destruction but also to cardiovascular, pulmonary, metabolic, and other extra-articular complications. This review focuses specifically on the translational potential of emerging recep...

Roshanak Fekri Yazdi, Sze Ian Tan, Wei-Feng Bu et al. · 0 citations
Review Open access Sep 2026

Osteoarthritis Therapeutics: From Microenvironment Understanding to Regenerative Intervention—Current Advances and Future Perspectives

This work provides an integrated theoretical and translational roadmap for next‐generation disease‐modifying OA therapies, focusing on how renewable biomaterials, engineered exosomes, and their composite systems target and regulate the pathological network to restore joint homeostasis.

Yong-Biao Meng, Shenghua Wu, Quan-Chun Liu · 0 citations
Open access Sep 2026

Immune heterogeneity-driven therapeutic responses to platelet-rich plasma and TRPV1 antagonism in osteoarthritis

These findings support a neuroimmune model in which synovial immune heterogeneity influences treatment responsiveness, and concurrent immune remodeling via PRP and nociceptor inhibition via TRPV1 antagonism represents a promising strategy to achieve more reliable analgesia in OA.

Peng Liu, Jing-Wei Zhu, Yang Yang et al. · 0 citations
Review Sep 2026

Curcumin as a natural therapeutic agent for osteoarthritis: molecular mechanisms, preclinical evidence, clinical applications, and future perspectives

Overall, curcumin represents a biologically plausible multitarget candidate for osteoarthritis, but larger, well-designed, standardized clinical trials incorporating structural and molecular endpoints are required to determine its therapeutic and disease-modifying potential.

Nalina Viswanathan, Vidhyavathi Ramasamy · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.